Evidence map›Paper›PMID 41634387›Full record

Observational studyQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2026

Predicting health-related quality of life for patients with gastroesophageal cancer.

Steven C Kuijper, Irene Cara, Gijs Geleijnse, Marije Slingerland, Grard A P Nieuwenhuijzen, Sjoerd M Lagarde, Bastiaan R Klarenbeek, Ewout A Kouwenhoven, Richard van Hillegersberg, Rob H A Verhoeven and 1 more

Abstract readObservational Study
In one paragraph

Observational study in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Steven C KuijperDepartment of Medical Oncology, Amsterdam UMC location University of Amsterdam, ZH 8D36, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Irene CaraDepartment of Medical Oncology, Amsterdam UMC location University of Amsterdam, ZH 8D36, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Gijs GeleijnseDepartment of Research & Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
Marije SlingerlandDepartment of Medical Oncology, Leiden University Medical center, Leiden, The Netherlands.
Grard A P NieuwenhuijzenDepartment of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
Sjoerd M LagardeDepartment of Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands.
Bastiaan R KlarenbeekDepartment of Surgery, Radboudumc, Arnhem, The Netherlands.
Ewout A KouwenhovenDepartment of Surgery, ZGT Hospital, Almelo, The Netherlands.
Richard van HillegersbergDepartment of Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands.
Rob H A VerhoevenDepartment of Medical Oncology, Amsterdam UMC location University of Amsterdam, ZH 8D36, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Hanneke W M van LaarhovenDepartment of Medical Oncology, Amsterdam UMC location University of Amsterdam, ZH 8D36, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. h.vanlaarhoven@amsterdamumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastroesophageal cancer has a poor prognosis, and treatment significantly impacts health-related quality of life (HRQoL). Accurate prediction of HRQoL changes after treatment can support shared decision-making. This study aimed to develop and validate HRQoL prediction models for patients with gastroesophageal cancer using established risk-prediction models and a newly proposed sequential score model.

methodsHRQoL data came from the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients registry, linked to the Netherlands Cancer Registry. The EORTC QLQ-C30 functioning scales were used as outcomes. Risk-prediction models, based on logistic elastic-net regression, estimated the probability of meaningful HRQoL deterioration at 3, 6, and 12 months post-treatment. The sequential score model, using XGBoost regression, predicted the next HRQoL score at any time. Calibration curves and integrated calibration index (ICI) assessed predictive performance, with Brier scores and AUC for risk-prediction models and root mean squared error plus Out-of-Sample r

resultsRisk-prediction models showed strong performance (ICI: 0.03-0.08; Brier score: 0.09-0.17; AUC: 0.79-0.87) for predicting significant deterioration in Summary Score, Physical Functioning, and Fatigue, with good calibration. Sequential score models explained up to 40% of the variance in HRQoL scores.

conclusionBoth models effectively predicted HRQoL in gastroesophageal cancer patients, demonstrating potential to enhance patient care and information sharing through accurate prediction of HRQoL outcomes.

Indexed as

Esophageal NeoplasmsQuality of LifeStomach NeoplasmsAgedFemaleHumansMaleMiddle AgedNetherlandsPrediction AlgorithmsProspective StudiesRegistriesSurveys and QuestionnairesElastic-netGastroesophageal cancerHealth-related quality of lifeMachine learningPrediction

Identifiers

PMID41634387
PMCPMC12868049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.